| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Codex DNA, Inc. | 10%+ Owner | Common Stock | 468,750 | $1,324,734 | $2.83 | 22 Jun 2021 | By: Northpond Ventures II, LP |
| Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 1,003,193 | 15 Oct 2024 | By Northpond Ventures II, LP | ||
| Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 763,636 | 15 Oct 2024 | By Northpond Ventures III, LP | ||
| Camp4 Therapeutics Corp | 10%+ Owner | Common Stock | 471,415 | 15 Oct 2024 | By Northpond Ventures, LP | ||
| Camp4 Therapeutics Corp | 10%+ Owner | Series A Prime Preferred Stock | 0 | 15 Oct 2024 | By Northpond Ventures II, LP | ||
| Camp4 Therapeutics Corp | 10%+ Owner | Series B Preferred Stock | 0 | 15 Oct 2024 | By Northpond Ventures, LP |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CAMP | Camp4 Therapeutics Corp | 15 Oct 2024 | 5 | +$8,399,996 | 4 | 10%+ Owner | 17 Oct 2024, 18:34 |
| CAMP | Camp4 Therapeutics Corp | 10 Oct 2024 | 0 | $0 | 3 | 10%+ Owner | 10 Oct 2024, 21:20 |
| TBIO | Codex DNA, Inc. | 22 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 24 Jun 2021, 16:22 |